Results 91 to 100 of about 6,976 (185)

Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients

, 2023
Victoria Wytiaz, Anne F. Schott, Aki Morikawa, Michelle M. Kim   +3 more
openalex   +1 more source

Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study [PDF]

Kamel Debbi, Marc‐Antoine Benderra, Jacques Médioni, C. Durdux, Nhu Hanh To, Chahrazed Boukhobza, N. Grellier, Asmahane Benmaziane, L Monnier, J. Gligorov, Elias Assaf, Y. Belkacemi   +11 more
openalex   +1 more source

Supplementary Appendix from Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors

, 2023
Shunji Takahashi, Masato Karayama, Masato Takahashi, Junichiro Watanabe, Hironobu Minami, Noboru Yamamoto, Ichiro Kinoshita, Chia‐Chi Lin, Young‐Hyuck Im, Issei Achiwa, Emi Kamiyama, Yasuyuki Okuda, Caleb Lee, Yung‐Jue Bang   +13 more
openalex   +1 more source

Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer

, 2022
Shuvadeep Ganguly, Ajay Gogia
openalex   +1 more source

Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post‐Authorization Safety Survey Among Physicians [PDF]

Angelika Wientzek, Ulf Stellmacher, Elisabeth Beyerlein, Annegret Gohlke, B. Ehlken   +4 more
openalex   +1 more source

Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer [PDF]

, 2022
Hope S. Rugo, Giampaolo Bianchini, Javier Cortés, Jan‐Willem Henning, Michael Untch   +4 more
openalex   +1 more source

Table S1, Table S2, Table S3 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

, 2023
Timothy P. DiPeri, Kurt W. Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q. Rizvi, Xiaofeng Zheng, Bailiang Wang, Bryce P. Kirby, Kathleen Kong, Michael Kahle, Timothy A. Yap, Ecaterina E. Dumbrava, Jaffer A. Ajani, Siqing Fu, Khandan Keyomarsi, Funda Meric‐Bernstam   +15 more
openalex   +1 more source

Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. [PDF]

Mol Cancer Ther
Burke CM, Feinberg TY, Brosius S, Bhanot UK, Jain M, Linkov I, Siddiquee A, Guillan K, Ibáñez G, Ndengu AA, Calder P, Rosales N, Coutinho DF, Long MM, Fishkin R, Thyparambil S, Glade Bender JL, Reed DR, You D, Ortiz MV, Slotkin EK, Kung AL, Dela Cruz FS.   +22 more
europepmc   +1 more source

Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review. [PDF]

J Clin Med
Orzelska J, Trzcińska A, Gierulska N, Lachowska K, Mazur K, Tarkowski R, Puzio I, Tomaszewska E, Kułak A, Kułak K.   +9 more
europepmc   +1 more source

Metastatic breast cancer with leptomeningeal carcinomatosis treated with trastuzumab deruxtecan - a case report. [PDF]

Oncoscience
Martins CH, Rocha JM, Portela C, Fernandes R, Caeiro C.   +4 more
europepmc   +1 more source